Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company's principal business activity is the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL...
-2 with superior CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program Targeted Metalloprotease Activated SuperKine (T-MASK) programs are designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Aug 09, 2023 2:03pm
Why the sell off , continued success with the pancreatic
cancer is huge .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Jul 26, 2023 7:16pm
RE:Looks like after all these years this company
Did I pick the bottom
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jul 25, 2023 11:22am
Looks like after all these years this company
is heading for the trash heap of failed pharmas .What happened to the brain ca ncer treatement .
(2)
•••
happyretirement
X
View Profile
View Bullboard History
Post by
happyretirement
on Feb 06, 2023 3:27pm
Tomorrow Quarter
Wonder if the word is out on the announcement of the quarter tomorrow. GLTA
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jan 26, 2023 3:35pm
Lowest I BOUGHT THIS IS .55 then I gave up .
nice surprise .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jan 17, 2023 2:03pm
This trades like a pre school project .
.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jan 11, 2023 1:45pm
Can we just get to 7.00 US thanks .
.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Dec 14, 2022 12:45am
Moderna with Keytruda .
Moderna cancer vaccine Moderna MRNA just added about $15 Billion in Market Cap today on news of a 44% improvement in melanoma when used in combo with Keytruda Vs Keytruda alone.
(79)
•••
thegreenmile656
X
View Profile
View Bullboard History
Post by
thegreenmile656
on Dec 07, 2022 9:22pm
Stock Therapy with Penny Queen: Medicenna Investor Update
Medicenna Investor Update Stock Therapy with Penny Queen
...more
(99)
•••
windymayor1
X
View Profile
View Bullboard History
Comment by
windymayor1
on Nov 25, 2022 9:17pm
RE:Greenish yeah !
Can you believe trading at cash value. with $7 and $9 US targets one has to pick a bit up down here. It could be back to $2.00 in a day's volume.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 24, 2022 4:25pm
Greenish yeah !
.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 21, 2022 3:15pm
Good news the rate of decline in the S/P is declining .
.
(99)
•••
windymayor1
X
View Profile
View Bullboard History
Comment by
windymayor1
on Nov 17, 2022 6:50pm
RE:Investors can't be happy with the daily new lows .
NASDAQ possible delisting after April '23?
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 17, 2022 12:41pm
Investors can't be happy with the daily new lows .
death by a thousand cuts
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 14, 2022 6:32pm
Down down down .
.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income